Long-term efficacy and renal safety of SGLT2 inhibitors in patients with heart failure and advanced chronic kidney disease (stage 4): a propensity score-matched retrospective cohort study - Quiz - MDSpire

Long-term efficacy and renal safety of SGLT2 inhibitors in patients with heart failure and advanced chronic kidney disease (stage 4): a propensity score-matched retrospective cohort study

  • By

  • Weihua Peng

  • Xiaoke Shang

  • Changdong Zhang

  • Mei Liu

  • June 17, 2026

  • 0 min

Share

Original Source(s)

Long-term efficacy and renal safety of SGLT2 inhibitors in patients with heart failure and advanced chronic kidney disease (stage 4): a propensity score-matched retrospective cohort study

  • by Weihua Peng, Xiaoke Shang, Changdong Zhang, Mei Liu

  • June 17, 2026

Related Content

“Double-hit” precipitates fulminant cardiac dysfunction in a child with homozygous CAP2 variant: a case report

Ischemia-modified albumin in children with clinically suspected acute myocarditis: diagnostic performance and incremental value beyond conventional biomarkers

Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants